Lanreotide Acetate Injection Shortage

• • Lanreotide acetate subcutaneous injection, Cipla USA, 120 mg/0.5 mL, prefilled syringe, NDC 69097-0870-67
  • Lanreotide acetate subcutaneous injection, Exelan Pharmaceuticals, 120 mg/0.5 mL, prefilled syringe, NDC 76282-0720-67

• • Cipla did not provide a reason for the shortage.
  • Exelan did not provide a reason for the shortage.
  • Ipsen Biopharmaceuticals has Somatuline Depot available.

• • Somatuline Depot subcutaneous injection, Ipsen Biopharmaceuticals, 120 mg/0.5 mL, prefilled syringe, NDC 15054-1120-04
  • Somatuline Depot subcutaneous injection, Ipsen Biopharmaceuticals, 60 mg/0.2 mL, prefilled syringe, NDC 15054-1060-04
  • Somatuline Depot subcutaneous injection, Ipsen Biopharmaceuticals, 90 mg/0.3 mL, prefilled syringe, NDC 15054-1090-04

Estimated Resupply Dates

• • Cipla has lanreotide 120 mg/0.5 mL prefilled syringes on intermittent back order and the company is releasing supplies as they become available.
  • Exelan has lanreotide 120 mg/0.5 mL prefilled syringes on back order and the company cannot estimate a release date.